Form 4 for NRXP NRX Pharmaceuticals, Inc.
Accepted 2022-11-18 00:00:00 ET · period of report 2022-11-16 · accession 0000880984-22-000015 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2022-11-18 | 2022-11-16+ | NRXP | Javitt Daniel C. | 10% | S - Sale | $1.03 | -166.7K | 9.66M | -2% | -$171.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | common stock | 2022-11-16 | S | D | 133,719 | $1.02 | 9,689,982 | I by Glytech LLC | — | — | (F2) Held by Glytech LLC of which the Reporting Person is the sole owner. |
| 2 | Common | common stock | 2022-11-17 | S | D | 33,018 | $1.05 | 9,656,964 | I by Glytech LLC | — | — | (F2) Held by Glytech LLC of which the Reporting Person is the sole owner. |